| Predictors of prescription errors involving anticancer chemotherapy agents. | |
| | |
MedLine Citation:
|
PMID: 22285178 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
AIM: The majority of medication errors that harm patients relate to the prescribing process. Our study aimed to identify the predictors of prescription errors involving anticancer chemotherapy agents. METHODS: All consecutive antineoplastic prescriptions from June 2006 to May 2008 were analysed, with medication errors being captured. Potential risk factors for medication prescribing errors were defined in relation to the patient, chemotherapy regimen and hospital organisation. The relationship between these risk factors and observed medication errors or dose medication errors was assessed by univariate and multivariate logistic-regression analyses. RESULTS: Among the 17,150 chemotherapy prescriptions, 540 contained at least one error (3.15%). The following independent predictors of risk of medication errors were identified: patients with a body surface area >2m(2) (odds ratio (OR): 1.3, 95% confidence interval (CI) 1.01-1.67, p=0.04), protocols with more than three drugs (OR: 1.91, 95%CI 1.59-2.31, p<0.001), protocols involving carboplatin (OR: 2.33, 95%CI 1.85-2.95, p<0.001), protocols requiring at least one modification by the physician (OR: 1.32, 95%CI 1.09-1.61, p=0.005), inpatient care (OR: 1.58, 95%CI 1.28-1.93, p<0.001) and prescriptions by a resident physician (OR: 1.83, 95%CI 1.50-2.22, p<0.001). The risk of medication dose prescribing errors was significantly associated with three independent factors: protocols involving carboplatin (OR: 4.47, 95%CI 3.45-5.79, p<0.001), protocols with more than three drugs (OR: 2.4, 95%CI 1.92-3.00, p<0.001) and protocols requiring at least one modification (OR: 1.33, 95%CI 1.04-1.69, p=0.02). CONCLUSION: In this epidemiologic study, the independent risk factors identified should be targeted for preventive measures in order to improve anticancer agent prescriptions and reduce the risk of medication errors. |
| | |
Authors:
|
Florence Ranchon; Céline Moch; Benoît You; Gilles Salles; Vérane Schwiertz; Nicolas Vantard; Emilie Franchon; Claude Dussart; Emilie Henin; Olivier Colomban; Pascal Girard; Gilles Freyer; Catherine Rioufol |
Related Documents
:
|
16562518 - Minimizing medical litigation, part 1. 22521808 - Association of chronic obstructive pulmonary disease maintenance medication adherence w... 2151308 - Histochemical findings of the tribocytic organ and tegument of fibricola seoulensis. 16749478 - Charles richet: medical scientist, innovator, peace thinker and savant. 19078408 - Minocycline hyperpigmentation. 717768 - Gas identity hazards and major contamination of the medical gas system of a new hospital. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-27 |
Journal Detail:
|
Title: European journal of cancer (Oxford, England : 1990) Volume: - ISSN: 1879-0852 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9005373 Medline TA: Eur J Cancer Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Hospices Civils de Lyon, Groupement Hospitalier Sud, Clinical Oncology Pharmacy Department - Université Lyon 1, Ecole Doctorale Interdisciplinaire Sciences Santé, Lyon, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sham-controlled, randomised, feasibility trial of acupuncture for prevention of radiation-induced xe...
Next Document: Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in hig...